Guizhou Xintian Pharmaceutical Co., Ltd.
Announcement on Major Shareholder's Equity Change Reaching 1% and Completion of Share Reduction Plan
Shanghai Xintianzhi Pharmaceutical Biotechnology Co., Ltd., the controlling shareholder, guarantees that the information provided to this company is true, accurate, and complete, with no false records, misleading statements, or material omissions.
This company and all members of the board of directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Guizhou Xintian Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "this Company") disclosed the "Announcement on the Pre-disclosure of Proposed Share Reduction by Controlling Shareholder" (Announcement No.: 2026-030) on May 8, 2026. The controlling shareholder, Shanghai Xintianzhi Pharmaceutical Biotechnology Co., Ltd. (hereinafter referred to as "Xintianzhi"), which holds 68,435,566 shares of the Company (accounting for 29.0847% of the total share capital after excluding shares in the repurchase account as of May 6, 2026), planned to reduce its holdings of the Company's shares through block trades and centralized bidding transactions, with a total reduction not exceeding 7,050,000 shares, accounting for 2.9962% of the total share capital after excluding shares in the repurchase account (of which: the reduction through block trades shall not exceed 4,700,000 shares, accounting for 6.8678% of its total holdings and 1.9975% of the total share capital after excluding shares in the repurchase account; the reduction through centralized bidding transactions shall not exceed 2,350,000 shares, accounting for 3.4339% of its total holdings and 0.9987% of the total share capital after excluding shares in the repurchase account).
On May 7, 2026, the Company sold 789,800 repurchased shares for the first time through centralized bidding transactions. The total share capital after excluding shares in the repurchase account increased from 235,297,776 shares to 236,087,576 shares. While the number of shares held by the controlling shareholder Xintianzhi remained unchanged, its shareholding proportion in the total share capital after excluding shares in the repurchase account was passively diluted from 29.0847% to 28.9874%, and the equity change reached 1%. For details, please refer to the "Announcement on Controlling Shareholder's Shareholding Proportion Reaching 1% Due to Passive Dilution" (Announcement No.: 2026-031) disclosed by the Company on May 9, 2026.
As of May 12, 2026, the Company had cumulatively sold 2,441,000 repurchased shares through centralized bidding transactions (including the initial sale of 789,800 shares on May 7, 2026). The total share capital after excluding shares in the repurchase account increased from 236,087,576 shares as of May 7, 2026, to 237,738,776 shares. While the number of shares held by the controlling shareholder Xintianzhi remained unchanged, its shareholding proportion in the total share capital after excluding shares in the repurchase account was passively diluted from 28.9874% to 28.7860%.
From June 8, 2026, to July 31, 2026, Xintianzhi cumulatively reduced its holdings by 2,300,000 shares through centralized bidding and block trades. Its shareholding proportion in the total share capital after excluding shares in the repurchase account changed from 28.7860% to 27.8186%, and the equity change reached 1%. For details, please refer to the "Announcement on Controlling Shareholder's Equity Change Reaching 1%" (Announcement No.: 2026-041) disclosed by the Company on August 4, 2026.
Recently, the Company received the "Notice on Controlling Shareholder's Shareholding Quantity Reaching 1% and Completion of Share Reduction Plan" issued by Xintianzhi. From August 3, 2026, to August 6, 2026, Xintianzhi cumulatively reduced its holdings of the Company's shares by 4,655,000 shares through centralized bidding and block trades. Its shareholding proportion in the total share capital after excluding shares in the repurchase account decreased from 27.8186% to 25.8606%, and the equity change reached 1%. As of the disclosure date of this announcement, this share reduction plan has been completed. The details are as follows: